With a market cap of $154.3 billion, Boston Scientific Corporation (BSX) is a global developer, manufacturer, and marketer of ...

This was the stock's second consecutive day of losses.

Boston Calling music festival won’t be held in 2026, organizers announce, but no one will say why By Dana Gerber and Mark Shanahan Globe Staff,Updated June 20, 2025, 10:59 a.m.

Boston Scientific Corporation (NYSE:BSX) is one of the best stocks to buy. On June 10, the company announced that it is selling one suburban Twin Cities property and expanding another, mirroring a ...

Cops, criminals, class conflict, Afflecks, and accents—why does Boston have its own movie subgenre? If you can't access your feeds, please contact customer support. Thanks! Check your phone for ...

Boston Scientific just scored a clean bill of health from analysts, with Leerink Partners launching coverage and slapping on an “outperform” rating along with a target price of $118. Twenty-two ...

Boston Scientific’s Operating Cash Flow (OCF) for the same period was $3.8 billion, indicating a good OCF margin of 21.7% compared to the S&P 500’s 14.9%.

Boston Scientific Corporation’s relative price strength rank of 70 means that its weighted four-quarter return ranks in the 70 th percentile of all U.S.-listed stocks. This score reflects the ...

Revenue Growth: Boston Scientific displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 20.93%.

Boston Scientific appears to be flexing a premium price tag that’s a bit too buff for its own balance sheet. Analysts using a two-stage Discounted Cash Flow (DCF) model calculated an intrinsic value ...